These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9190637)

  • 1. [The influence of multiple dialyzer reuse on selected coagulation parameters].
    Juźwiuk J; Popławski A; Mazerska M; Pawlak K
    Przegl Lek; 1997; 54(1):6-9. PubMed ID: 9190637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialyzer reprocessing with peroxyacetic acid as sole cleansing and sterilizing agent.
    Kes P; Reiner Z; Ratković-Gusić I
    Acta Med Croatica; 1997; 51(2):87-93. PubMed ID: 9204593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of erythropoietin treatment on the coagulation system during standardized hemodialysis.
    Clyne N; Lins LE; Egberg N
    Clin Nephrol; 1995 Apr; 43(4):260-7. PubMed ID: 7606881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
    Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit.
    Lucchi L; Ligabue G; Marietta M; Delnevo A; Malagoli M; Perrone S; Stipo L; Grandi F; Albertazzi A
    Artif Organs; 2006 Feb; 30(2):106-10. PubMed ID: 16433843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved dialyzer reuse after use of a population pharmacodynamic model to determine heparin doses.
    Ouseph R; Brier ME; Ward RA
    Am J Kidney Dis; 2000 Jan; 35(1):89-94. PubMed ID: 10620549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical study to assess the effect of heparin in dialyzer rinsing solutions.
    Opatrný K; Bouda M; Kohoutková L; Vít L; Sefrna F
    Int J Artif Organs; 1997 Feb; 20(2):112-8. PubMed ID: 9093891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
    Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
    Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
    Burmeister JE; Scapini A; da Rosa Miltersteiner D; da Costa MG; Campos BM
    Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in platelet function during hemodialysis.
    Levin RD; Kwaan HC; Ivanovich P
    J Lab Clin Med; 1978 Nov; 92(5):779-86. PubMed ID: 712209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some parameters of platelet activation in patients with uremia before and after hemodialysis (HD)].
    Dymicka-Piekarska V; Matowicka-Karna J; Mantur M; Kemona H; Piszka J
    Przegl Lek; 2002; 59(12):980-3. PubMed ID: 12731371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of platelet hemostasis in patients with chronic renal failure].
    Krawczyk W; Dmoszyńska A; Sokołowska B
    Wiad Lek; 1994 Feb; 47(3-4):93-9. PubMed ID: 7975649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
    Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
    Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with urea reduction ratio in acute renal failure.
    Liangos O; Rao M; Ruthazer R; Balakrishnan VS; Modi G; Pereira BJ; Jaber BL
    Artif Organs; 2004 Dec; 28(12):1076-81. PubMed ID: 15554935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study of IL-1 beta, TNF-alpha, IL-6 gene expression and plasma levels on hemodialysis before and after dialyzer reuse.
    Qian J; Yu Z; Dai H; Huang P; Zhang Q; Cheng F; Chen S
    Chin Med J (Engl); 1997 Jul; 110(7):508-11. PubMed ID: 9594206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.